Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017

Details for Mechanism ID: 17850
Country/Region: Angola
Year: 2016
Main Partner: Columbia University
Main Partner Program: Mailman School of Public Health
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $1,856,681 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $28,073
Care: TB/HIV (HVTB) $150,000
Care: Pediatric Care and Support (PDCS) $64,436
Strategic Information (HVSI) $330,000
Health Systems Strengthening (OHSS) $139,372
Testing: HIV Testing and Counseling (HVCT) $91,867
Treatment: Adult Treatment (HTXS) $665,317
Treatment: Pediatric Treatment (PDTX) $387,616
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 1,061
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 990
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 10,016
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 8,012
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 20,079
HTS_TST Service Delivery Point (Facility): Index testing 2017 2,612
HTS_TST Service Delivery Point (Facility): Inpatient 2017 605
HTS_TST Service Delivery Point (Facility): Other PITC 2017 7,204
HTS_TST Service Delivery Point (Facility): Outpatient 2017 644
HTS_TST Service Delivery Point (Facility): Pediatric 2017 194
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 8,820
HTS_TST Sum of Aggregated Age/Sex <15 2017 2,051
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 18,028
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 20,079
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 174
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 157
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,267
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,033
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 62
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 415
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 83
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 551
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 1,588
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 1,111
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 493
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 3,298
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 655
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 4,374
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 8,820
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 9,800
TX_CURR Aggregated Age/Sex: <15 Female 2017 1,918
TX_CURR Aggregated Age/Sex: <15 Male 2017 1,825
TX_CURR Aggregated Age/Sex: 15+ Female 2017 14,597
TX_CURR Aggregated Age/Sex: 15+ Male 2017 7,077
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 25,417
TX_CURR Sum of Aggregated Age/Sex <15 2017 3,743
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 21,674
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 25,417
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 612
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 551
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 4,446
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 2,144
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 7,753
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 7,753
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 15,000
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 10,950
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 853
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 807
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 6,256
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 3,034
TX_PVLS Numerator: Indication: Routine 2017 9,308
TX_PVLS Numerator: Indication: Targeted 2017 1,642
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 1,167
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 1,106
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 8,572
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 4,155
TX_PVLS_den Denominator: Indication: Routine 2017 12,747
TX_PVLS_den Denominator: Indication: Targeted 2017 2,253
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,395
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 746
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,978
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,606
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 6,725
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 8,406
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,743
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 933
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,722
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,008